Investor Slashes Million From Zymeworks as Stock Jumps 60%
A large holder trimmed a substantial stake in a biotech name while the stock advanced. This piece explains what inves...
Not all retirees benefit equally from Target Date Funds. This guide points out scenarios and preferences where avoidance may be wise.
27,346 articlesA large holder trimmed a substantial stake in a biotech name while the stock advanced. This piece explains what inves...
Canadian Solar's Q4 2025 results set the stage for 2025. This deep dive explains what to watch, the margin trajectory...
A domestic uranium producer is expanding beyond ore to processing key minerals. This article breaks down the strategy...
When planet fitness stock plunged after the latest earnings, investors suddenly faced a tough question: buy the dip o...
A safety scare isn’t just about security—it's a financial moment too. This guide explains how to align risk managemen...
Amazon just announced shocking debt plans to fund its data-center expansion. This in-depth analysis breaks down what ...
A sudden, sizable stake in Resideo Technologies has sent its stock climbing 66%. Alta Fox Capital Management disclose...
When digital assets are seized, custody rules matter as much as the seizure itself. This article breaks down what hap...
Pope Leo XIV releases Magnifica Humanitas, an AI-focused encyclical urging human-centered tech and fair wages, igniti...
CNBS traders are weighing a high-conviction cannabis theme against a thin dividend base. The ETF leans on one rent-pr...
Canopy Growth has seen dramatic swings, trading under $2 after years of highs. This guide breaks down what could push...
Warren Buffett built a blueprint for successful long term investing. Here are three no-brainer Warren Buffett stocks ...